click below
click below
Normal Size Small Size show me how
10.1.25 aml Rx law
| Term | Definition |
|---|---|
| Obra '90 Omnibus Budget Reconciliation Act of 1990 | Congressional act that changed reimbursement limits and mandated drug use evaluation, pharmacy patient consolation, and educational outreach program. |
| Humanitarian Device Exemption - Safe Medical Devices Act (SMDA) | encourages discovery and use of devices intended to treat patients in treatment and diagnosis of extremely rare diseases |
| Dietary Supplement Health and Education Act (DSHEA) | This act defines, "Dietary Supplements", Herbs must label themselves correctly and not mislead costumers |
| Health Insurance Portability and Accountability Act (HIPAA) [and PHI] | Federal Act that protects patient's rights, establishes national standards for electronic health care communication, and ensures the security and privacy of health data. |
| Drug Addiction Treatment Act (DATA 2000) | permits physicians to prescribe controlled substances to patients with opioid addictions for maintenance or detoxification treatments |
| Medicare Modernization Act (MMA) | (set the stage for MTM) provided a drug discount card to patients with low incomes for any prescriptions |
| Combat Methamphetamine Epidemic Act (CMEA) | This act amended the Controlled Substance Act. Pseudoephedrine must be sold by trained personnel and manufactures could only sell this drug to retailers under the DEA. |
| Dietary Supplement and Nonprescription Drug Consumer Protection Act | amends the Federal Food, Drug, and Cosmetic Act to require manufacturers, packers, and distributors of dietary supplements and nonprescription drugs to report serious adverse events associated with their products. |
| Physician's Labeling Rule (PLR) | one of the many reference books on medication; complies and publishes select manufacturer-provided package inserts and prescribing information for health professionals |
| Patient Protection and Affordable Care Act (ACA); "Obamacare" | Makes preventative care more accessible |
| Drug Quality and Security Act (DQSA) | gave FDA greater oversight over bulk pharmaceutical compounding and enhances agency's ability to track drugs through distribution process |
| Recall Class 1 | Highest level; deals with products that could cause serious harm or death. EX. life-saving drugs and foods that contain toxins |
| Recall Class 2 | middle level: deals with product found to cause temporary health issues or threat of serious harm. EX. drugs dispensed at lower strength |
| Recall Class 3 | Lowest level: products with minor defects that will not cause harm but cannot be resold. EX, faulty cap or lack of English on labeling |